Neurogene (NGNE) Research & Development (2018 - 2025)
Historic Research & Development for Neurogene (NGNE) over the last 4 years, with Q3 2025 value amounting to $17.2 million.
- Neurogene's Research & Development rose 587.04% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.7 million, marking a year-over-year increase of 2070.85%. This contributed to the annual value of $60.9 million for FY2024, which is 3721.9% up from last year.
- According to the latest figures from Q3 2025, Neurogene's Research & Development is $17.2 million, which was up 587.04% from $19.4 million recorded in Q2 2025.
- Neurogene's 5-year Research & Development high stood at $19.4 million for Q2 2025, and its period low was $10.3 million during Q1 2023.
- Moreover, its 3-year median value for Research & Development was $15.3 million (2024), whereas its average is $14.5 million.
- As far as peak fluctuations go, Neurogene's Research & Development skyrocketed by 5254.34% in 2024, and later skyrocketed by 587.04% in 2025.
- Quarter analysis of 3 years shows Neurogene's Research & Development stood at $12.2 million in 2023, then increased by 25.96% to $15.3 million in 2024, then rose by 12.34% to $17.2 million in 2025.
- Its Research & Development was $17.2 million in Q3 2025, compared to $19.4 million in Q2 2025 and $17.8 million in Q1 2025.